Natus Medical Soars. It's Being Taken Private by ArchiMed for $1.2 Billion.

Neurodiagnostic Focused Natus Medical Goes Private In $1.2B Deal

Natus Medical to be acquired at a 29% premium by ArchiMed

A Preview Of Natus Medical's Earnings

The Daily Biotech Pulse: Voyager, AbbVie End Collaboration, Thumbs Down For DBV's Peanut Allergy Patch, Tiziana Expedites COVID-19 Trial Plans

The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter

The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings

Natus Medical Incorporated (NASDAQ:NTUS) Shares Sold by Invesco Ltd.